118
Participants
Start Date
June 30, 2014
Primary Completion Date
January 31, 2016
Study Completion Date
June 30, 2016
birinapant
Azacitidine
Placebo
Royal Prince Alfred Hospital, Camperdown
Westmead Hospital, Westmead
The Alfred, Melbourne
Austin Health, Heidelberg
Cabrini Hospital, Malvern
Border Medical Oncology, Wodonga
Metro South Health, Princess Alexandra Hospital, Woolloongabba
Royal Adelaide Hospital, Adelaide
Perth Blood Institute, Nedlands
Royal Hobart Hospital, Hobart
Columbia University Medical Center, New York
Weill Cornell Medical College - New York-Presbyterian Hospital, New York
Montefiore Medical Center, The Bronx
Monter Cancer Center, Lake Success
North Shore Hematology Oncology Associates, East Setauket
Hospital University Reina Sofia, Córdoba
Penn State Milton S. Hershey Medical Center, Hershey
University of Maryland, Greenebaum Cancer Center, Baltimore
Virginia Commonwealth University Massey Cancer Center, Richmond
Duke University Medical Center, Durham
Hospital Universitario Gregorio Maranon, Madrid
MD Anderson Cancer Center, Madrid
Hospital Universitario Severo Ochoa, Leganés
Medical University of South Carolina, Hollings Cancer Center, Charleston
Carolina Blood and Cancer Care Associates, P.A., Rock Hill
Hospital Clinico Universitario Virgen de la Arrixaca, El Palmar
Medizinische Hochschule Hannover, Hanover
Clinica Universidad de Navarra, Pamplona
Cancer Specialists of North Florida, Jacksonville
Mayo Clinic Jacksonville, Jacksonville
H. Lee Moffitt Cancer Center & Research Institute, Tampa
Bond Clinic PA, Winter Haven
Hematology Oncology Associates of the Treasure Coast, Port Saint Lucie
Hospital Universitario de Salamanca, Salamanca
Tennessee Oncology, Nashville
Tennessee Oncology, Chattanooga
Hospital Universitario de Canarias, San Cristóbal de La Laguna
University of Louisville Hospital/James Graham Brown Cancer Center, Louisville
Marien Hospital Dusseldorf, Düsseldorf
Gabrail Cancer Center Research, Canton
Complejo Hospitalario Virgen de la Salud, Toledo
Universitatsklinikum Essen, Essen
Oncology Hematology Care, Inc., Cincinnati
Hospital Clinico Universitario de Valencia, Valencia
St. Joseph Mercy Hospital, Ann Arbor
University Hospital of Cologne, Cologne
University of Iowa Hospitals and Clinics, Iowa City
Loyola University Medical Center, Maywood
Simmons Cancer Institute at Southern Illinois University, Springfield
Medizinische Universitatsklinik Heidelberg, Heidelberg
Tulane Medical Center, New Orleans
Tyler Hematology Oncology PA, Tyler
The University of Texas MD Anderson Cancer Center, Houston
Colorado Blood Cancer Institute, Denver
Klinikum der Ludwig-Maximilians-Universitat Munchen, Munich
Klinikum Rechts der Isar, Technischen Universitat Munchen, München
Utah Cancer Specialists, Salt Lake City
University of Utah, Huntsman Cancer Hospital, Salt Lake City
Mayo Clinic, Scottsdale
Palo Verde Hematology Oncology, Glendale
Arizona Center for Cancer Care, Glendale
Arizona Oncology Associates, Tucson
University of New Mexico Cancer Center, Albuquerque
Ronald Reagan UCLA Medical Center, Los Angeles
Wellness Oncology & Hematology, West Hills
North County Oncology, Oceanside
Desert Hematology Oncology Medical Group, Rancho Mirage
Stanford Hospital and Clinics, Stanford
Universitatsklinikum Wurzburg, Würzburg
Oregon Health and Sciences University, Portland
Seattle Cancer Care Alliance, Seattle
University of Massachusetts Worcester, Worcester
New Jersey Hematology Oncology Associates, Brick
Hackensack University Medical Center, Hackensack
University Hospital Halle, Halle
Hospital Germans Trias I Pujol, Badalona
Lead Sponsor
TetraLogic Pharmaceuticals
INDUSTRY